Form 4 for RXST RxSight, Inc.
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0000899243-21-031831 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-05 | 2021-08-03 | RXST | Schwartz Daniel Mark | Dir | C - Cnv Deriv | $0.00 | +3,969 | 407.6K | +1.0% | $0 |
| D | 2021-08-05 | 2021-08-03 | RXST | Schwartz Daniel Mark | Dir | C - Cnv Deriv | $0.00 | -3,872 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | C | A | 3,969 | $0.00 | 407,647 | D | — | — | (F1) All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. (F2) The number of shares reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly overstated the number of shares held by 11,012 shares. The correct number of shares should have been reported as 403,678. |
| 2 | Derivative | Series C Preferred Stock | 2021-08-03 | C | D | 3,872 | $0.00 | 0 | D | — · — to — | 3,969 Common Stock | (F1) All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. |